HEADER HYDROLASE/HYDROLASE INHIBITOR 18-MAY-15 4ZVT TITLE CASPASE-7 VARIANT 1 (V1) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TITLE 2 TO Y230A/W232M/S234N SUBSTITUTIONS, BOUND TO VEID INHIBITOR. COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-7; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: UNP RESIDUES 34-231; COMPND 5 SYNONYM: CASP-7,APOPTOTIC PROTEASE MCH-3,CMH-1,ICE-LIKE APOPTOTIC COMPND 6 PROTEASE 3,ICE-LAP3; COMPND 7 EC: 3.4.22.60; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: CASPASE-7; COMPND 11 CHAIN: B, D; COMPND 12 FRAGMENT: UNP RESIDUES 232-336; COMPND 13 SYNONYM: CASP-7,APOPTOTIC PROTEASE MCH-3,CMH-1,ICE-LIKE APOPTOTIC COMPND 14 PROTEASE 3,ICE-LAP3; COMPND 15 EC: 3.4.22.60; COMPND 16 ENGINEERED: YES; COMPND 17 MUTATION: YES; COMPND 18 MOL_ID: 3; COMPND 19 MOLECULE: VEID INHIBITOR; COMPND 20 CHAIN: E, F; COMPND 21 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP7, MCH3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: CASP7, MCH3; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 14 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 18 ORGANISM_TAXID: 32630 KEYWDS DIRECTED EVOLUTION, PROTEASE, PEPTIDE INHIBITOR, DESIGNED ACTIVE SITE KEYWDS 2 SPECIFICITY, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.A.HARDY,D.J.MACPHERSON,M.E.HILL REVDAT 6 15-NOV-23 4ZVT 1 REMARK REVDAT 5 27-SEP-23 4ZVT 1 REMARK REVDAT 4 25-DEC-19 4ZVT 1 REMARK REVDAT 3 20-SEP-17 4ZVT 1 REMARK REVDAT 2 06-JUL-16 4ZVT 1 JRNL REVDAT 1 20-APR-16 4ZVT 0 JRNL AUTH M.E.HILL,D.J.MACPHERSON,P.WU,O.JULIEN,J.A.WELLS,J.A.HARDY JRNL TITL REPROGRAMMING CASPASE-7 SPECIFICITY BY REGIO-SPECIFIC JRNL TITL 2 MUTATIONS AND SELECTION PROVIDES ALTERNATE SOLUTIONS FOR JRNL TITL 3 SUBSTRATE RECOGNITION. JRNL REF ACS CHEM.BIOL. V. 11 1603 2016 JRNL REFN ESSN 1554-8937 JRNL PMID 27032039 JRNL DOI 10.1021/ACSCHEMBIO.5B00971 REMARK 2 REMARK 2 RESOLUTION. 2.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.25 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.910 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 20086 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.840 REMARK 3 FREE R VALUE TEST SET COUNT : 972 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3777 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 4 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.16 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.400 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4ZVT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-MAY-15. REMARK 100 THE DEPOSITION ID IS D_1000209188. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-JUN-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : OSMIC BLUE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM 7.0.9 REMARK 200 DATA SCALING SOFTWARE : SCALA 0.1.27 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20141 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.850 REMARK 200 RESOLUTION RANGE LOW (A) : 59.160 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.12200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.50 REMARK 200 R MERGE FOR SHELL (I) : 0.69600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.1 REMARK 200 STARTING MODEL: 3EDR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 300 MM DIAMMONIUM HYDROGEN CITRATE, REMARK 280 14% PEG 3350, 10 MM GUANIDINIUM CHLORIDE, 10 MM DITHIOTHERITOL, REMARK 280 PH 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 124.32733 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 62.16367 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 62.16367 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 124.32733 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 15940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17830 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -91.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE N-ACETYL-L-VALYL-L-ALPHA-GLUTAMYL-N-[(2S)-1-CARBOXY-3- REMARK 400 HYDROXYPROPAN-2-YL]-L-ISOLEUCINAMIDE IS PEPTIDE-LIKE, A MEMBER OF REMARK 400 INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: N-ACETYL-L-VALYL-L-ALPHA-GLUTAMYL-N-[(2S)-1-CARBOXY-3- REMARK 400 HYDROXYPROPAN-2-YL]-L-ISOLEUCINAMIDE REMARK 400 CHAIN: E, F REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ASP A 3 REMARK 465 ASP A 4 REMARK 465 GLN A 5 REMARK 465 GLY A 6 REMARK 465 CYS A 7 REMARK 465 ILE A 8 REMARK 465 GLU A 9 REMARK 465 GLU A 10 REMARK 465 GLN A 11 REMARK 465 GLY A 12 REMARK 465 VAL A 13 REMARK 465 GLU A 14 REMARK 465 ASP A 15 REMARK 465 SER A 16 REMARK 465 ALA A 17 REMARK 465 ASN A 18 REMARK 465 GLU A 19 REMARK 465 ASP A 20 REMARK 465 SER A 21 REMARK 465 VAL A 22 REMARK 465 ASP A 23 REMARK 465 ALA A 24 REMARK 465 LYS A 25 REMARK 465 PRO A 26 REMARK 465 ASP A 27 REMARK 465 ARG A 28 REMARK 465 SER A 29 REMARK 465 SER A 30 REMARK 465 PHE A 31 REMARK 465 VAL A 32 REMARK 465 PRO A 33 REMARK 465 SER A 34 REMARK 465 LEU A 35 REMARK 465 PHE A 36 REMARK 465 SER A 37 REMARK 465 LYS A 38 REMARK 465 LYS A 39 REMARK 465 LYS A 40 REMARK 465 LYS A 41 REMARK 465 ASN A 42 REMARK 465 VAL A 43 REMARK 465 THR A 44 REMARK 465 MET A 45 REMARK 465 ARG A 46 REMARK 465 SER A 47 REMARK 465 ILE A 48 REMARK 465 LYS A 49 REMARK 465 THR A 50 REMARK 465 THR A 51 REMARK 465 ARG A 52 REMARK 465 ASP A 53 REMARK 465 ARG A 54 REMARK 465 VAL A 55 REMARK 465 PRO A 56 REMARK 465 THR A 57 REMARK 465 ALA A 197 REMARK 465 ASP A 198 REMARK 465 SER B 199 REMARK 465 GLY B 200 REMARK 465 PRO B 201 REMARK 465 ILE B 202 REMARK 465 ASN B 203 REMARK 465 ASP B 204 REMARK 465 THR B 205 REMARK 465 ASP B 206 REMARK 465 ALA B 207 REMARK 465 ASN B 208 REMARK 465 PRO B 209 REMARK 465 ARG B 210 REMARK 465 LEU B 304 REMARK 465 GLU B 305 REMARK 465 HIS B 306 REMARK 465 HIS B 307 REMARK 465 HIS B 308 REMARK 465 HIS B 309 REMARK 465 HIS B 310 REMARK 465 HIS B 311 REMARK 465 MET C 301 REMARK 465 ALA C 302 REMARK 465 ASP C 303 REMARK 465 ASP C 304 REMARK 465 GLN C 305 REMARK 465 GLY C 306 REMARK 465 CYS C 307 REMARK 465 ILE C 308 REMARK 465 GLU C 309 REMARK 465 GLU C 310 REMARK 465 GLN C 311 REMARK 465 GLY C 312 REMARK 465 VAL C 313 REMARK 465 GLU C 314 REMARK 465 ASP C 315 REMARK 465 SER C 316 REMARK 465 ALA C 317 REMARK 465 ASN C 318 REMARK 465 GLU C 319 REMARK 465 ASP C 320 REMARK 465 SER C 321 REMARK 465 VAL C 322 REMARK 465 ASP C 323 REMARK 465 ALA C 324 REMARK 465 LYS C 325 REMARK 465 PRO C 326 REMARK 465 ASP C 327 REMARK 465 ARG C 328 REMARK 465 SER C 329 REMARK 465 SER C 330 REMARK 465 PHE C 331 REMARK 465 VAL C 332 REMARK 465 PRO C 333 REMARK 465 SER C 334 REMARK 465 LEU C 335 REMARK 465 PHE C 336 REMARK 465 SER C 337 REMARK 465 LYS C 338 REMARK 465 LYS C 339 REMARK 465 LYS C 340 REMARK 465 LYS C 341 REMARK 465 ASN C 342 REMARK 465 VAL C 343 REMARK 465 THR C 344 REMARK 465 MET C 345 REMARK 465 ARG C 346 REMARK 465 SER C 347 REMARK 465 ILE C 348 REMARK 465 LYS C 349 REMARK 465 THR C 350 REMARK 465 THR C 351 REMARK 465 ARG C 352 REMARK 465 ASP C 353 REMARK 465 ARG C 354 REMARK 465 VAL C 355 REMARK 465 PRO C 356 REMARK 465 ALA C 497 REMARK 465 ASP C 498 REMARK 465 SER D 499 REMARK 465 GLY D 500 REMARK 465 PRO D 501 REMARK 465 ILE D 502 REMARK 465 ASN D 503 REMARK 465 ASP D 504 REMARK 465 THR D 505 REMARK 465 ASP D 506 REMARK 465 ALA D 507 REMARK 465 ASN D 508 REMARK 465 PRO D 509 REMARK 465 ARG D 510 REMARK 465 LEU D 604 REMARK 465 GLU D 605 REMARK 465 HIS D 606 REMARK 465 HIS D 607 REMARK 465 HIS D 608 REMARK 465 HIS D 609 REMARK 465 HIS D 610 REMARK 465 HIS D 611 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 80 CG CD CE NZ REMARK 480 ASP B 278 CB CG OD1 OD2 REMARK 480 HIS B 281 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 148 -3.38 73.98 REMARK 500 CYS A 171 79.23 -159.83 REMARK 500 HIS B 252 11.91 -140.49 REMARK 500 ASP B 278 53.60 -92.34 REMARK 500 PHE B 301 34.40 -88.17 REMARK 500 ASN C 448 -1.12 71.77 REMARK 500 CYS C 471 76.91 -157.65 REMARK 500 HIS D 552 11.47 -144.00 REMARK 500 SER D 577 145.61 -173.07 REMARK 500 GLU D 584 16.23 81.30 REMARK 500 PHE D 601 31.58 -87.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4ZVS RELATED DB: PDB REMARK 900 CASPASE-7 Y230A/W232M/S234N BOUND TO DEVD INHIBITOR REMARK 900 RELATED ID: 4ZVU RELATED DB: PDB REMARK 900 CASPASE-7 WILD-TYPE BOUND TO TETRAPEPTIDE INHIBITOR AC-VEID-CHO REMARK 900 RELATED ID: 4ZVQ RELATED DB: PDB REMARK 900 CASPASE-7 Y230V/W232M/Q276C BOUND TO VEID INHIBITOR REMARK 900 RELATED ID: 4ZVP RELATED DB: PDB REMARK 900 CASPASE-7 Y230V/W232M/Q276C BOUND TO DEVD INHIBITOR REMARK 900 RELATED ID: 4ZVO RELATED DB: PDB REMARK 900 CASPASE-7 Y230V/W232Y/S234V/Q276D BOUND TO VEID INHIBITOR REMARK 900 RELATED ID: 4ZVR RELATED DB: PDB REMARK 900 CASPASE-7 Y230V/W232Y/S234V/Q276D BOUND TO DEVD INHIBITOR REMARK 900 RELATED ID: 1F1J RELATED DB: PDB REMARK 900 WILD-TYPE CASPASE-7 BOUND TO DEVD INHIBITOR REMARK 900 RELATED ID: 3EDR RELATED DB: PDB REMARK 900 WILD-TYPE CASPASE-7 BOUND TO LDESD INBIBITOR DBREF 4ZVT A 1 198 UNP P55210 CASP7_HUMAN 1 198 DBREF 4ZVT B 199 303 UNP P55210 CASP7_HUMAN 199 303 DBREF 4ZVT C 301 498 UNP P55210 CASP7_HUMAN 1 198 DBREF 4ZVT D 499 603 UNP P55210 CASP7_HUMAN 199 303 DBREF 4ZVT E 0 4 PDB 4ZVT 4ZVT 0 4 DBREF 4ZVT F 0 4 PDB 4ZVT 4ZVT 0 4 SEQADV 4ZVT ALA B 230 UNP P55210 TYR 230 ENGINEERED MUTATION SEQADV 4ZVT MET B 232 UNP P55210 TRP 232 ENGINEERED MUTATION SEQADV 4ZVT ASN B 234 UNP P55210 SER 234 ENGINEERED MUTATION SEQADV 4ZVT LEU B 304 UNP P55210 EXPRESSION TAG SEQADV 4ZVT GLU B 305 UNP P55210 EXPRESSION TAG SEQADV 4ZVT HIS B 306 UNP P55210 EXPRESSION TAG SEQADV 4ZVT HIS B 307 UNP P55210 EXPRESSION TAG SEQADV 4ZVT HIS B 308 UNP P55210 EXPRESSION TAG SEQADV 4ZVT HIS B 309 UNP P55210 EXPRESSION TAG SEQADV 4ZVT HIS B 310 UNP P55210 EXPRESSION TAG SEQADV 4ZVT HIS B 311 UNP P55210 EXPRESSION TAG SEQADV 4ZVT ALA D 530 UNP P55210 TYR 230 ENGINEERED MUTATION SEQADV 4ZVT MET D 532 UNP P55210 TRP 232 ENGINEERED MUTATION SEQADV 4ZVT ASN D 534 UNP P55210 SER 234 ENGINEERED MUTATION SEQADV 4ZVT LEU D 604 UNP P55210 EXPRESSION TAG SEQADV 4ZVT GLU D 605 UNP P55210 EXPRESSION TAG SEQADV 4ZVT HIS D 606 UNP P55210 EXPRESSION TAG SEQADV 4ZVT HIS D 607 UNP P55210 EXPRESSION TAG SEQADV 4ZVT HIS D 608 UNP P55210 EXPRESSION TAG SEQADV 4ZVT HIS D 609 UNP P55210 EXPRESSION TAG SEQADV 4ZVT HIS D 610 UNP P55210 EXPRESSION TAG SEQADV 4ZVT HIS D 611 UNP P55210 EXPRESSION TAG SEQRES 1 A 198 MET ALA ASP ASP GLN GLY CYS ILE GLU GLU GLN GLY VAL SEQRES 2 A 198 GLU ASP SER ALA ASN GLU ASP SER VAL ASP ALA LYS PRO SEQRES 3 A 198 ASP ARG SER SER PHE VAL PRO SER LEU PHE SER LYS LYS SEQRES 4 A 198 LYS LYS ASN VAL THR MET ARG SER ILE LYS THR THR ARG SEQRES 5 A 198 ASP ARG VAL PRO THR TYR GLN TYR ASN MET ASN PHE GLU SEQRES 6 A 198 LYS LEU GLY LYS CYS ILE ILE ILE ASN ASN LYS ASN PHE SEQRES 7 A 198 ASP LYS VAL THR GLY MET GLY VAL ARG ASN GLY THR ASP SEQRES 8 A 198 LYS ASP ALA GLU ALA LEU PHE LYS CYS PHE ARG SER LEU SEQRES 9 A 198 GLY PHE ASP VAL ILE VAL TYR ASN ASP CYS SER CYS ALA SEQRES 10 A 198 LYS MET GLN ASP LEU LEU LYS LYS ALA SER GLU GLU ASP SEQRES 11 A 198 HIS THR ASN ALA ALA CYS PHE ALA CYS ILE LEU LEU SER SEQRES 12 A 198 HIS GLY GLU GLU ASN VAL ILE TYR GLY LYS ASP GLY VAL SEQRES 13 A 198 THR PRO ILE LYS ASP LEU THR ALA HIS PHE ARG GLY ASP SEQRES 14 A 198 ARG CYS LYS THR LEU LEU GLU LYS PRO LYS LEU PHE PHE SEQRES 15 A 198 ILE GLN ALA CYS ARG GLY THR GLU LEU ASP ASP GLY ILE SEQRES 16 A 198 GLN ALA ASP SEQRES 1 B 113 SER GLY PRO ILE ASN ASP THR ASP ALA ASN PRO ARG TYR SEQRES 2 B 113 LYS ILE PRO VAL GLU ALA ASP PHE LEU PHE ALA TYR SER SEQRES 3 B 113 THR VAL PRO GLY TYR ALA SER MET ARG ASN PRO GLY ARG SEQRES 4 B 113 GLY SER TRP PHE VAL GLN ALA LEU CYS SER ILE LEU GLU SEQRES 5 B 113 GLU HIS GLY LYS ASP LEU GLU ILE MET GLN ILE LEU THR SEQRES 6 B 113 ARG VAL ASN ASP ARG VAL ALA ARG HIS PHE GLU SER GLN SEQRES 7 B 113 SER ASP ASP PRO HIS PHE HIS GLU LYS LYS GLN ILE PRO SEQRES 8 B 113 CYS VAL VAL SER MET LEU THR LYS GLU LEU TYR PHE SER SEQRES 9 B 113 GLN LEU GLU HIS HIS HIS HIS HIS HIS SEQRES 1 C 198 MET ALA ASP ASP GLN GLY CYS ILE GLU GLU GLN GLY VAL SEQRES 2 C 198 GLU ASP SER ALA ASN GLU ASP SER VAL ASP ALA LYS PRO SEQRES 3 C 198 ASP ARG SER SER PHE VAL PRO SER LEU PHE SER LYS LYS SEQRES 4 C 198 LYS LYS ASN VAL THR MET ARG SER ILE LYS THR THR ARG SEQRES 5 C 198 ASP ARG VAL PRO THR TYR GLN TYR ASN MET ASN PHE GLU SEQRES 6 C 198 LYS LEU GLY LYS CYS ILE ILE ILE ASN ASN LYS ASN PHE SEQRES 7 C 198 ASP LYS VAL THR GLY MET GLY VAL ARG ASN GLY THR ASP SEQRES 8 C 198 LYS ASP ALA GLU ALA LEU PHE LYS CYS PHE ARG SER LEU SEQRES 9 C 198 GLY PHE ASP VAL ILE VAL TYR ASN ASP CYS SER CYS ALA SEQRES 10 C 198 LYS MET GLN ASP LEU LEU LYS LYS ALA SER GLU GLU ASP SEQRES 11 C 198 HIS THR ASN ALA ALA CYS PHE ALA CYS ILE LEU LEU SER SEQRES 12 C 198 HIS GLY GLU GLU ASN VAL ILE TYR GLY LYS ASP GLY VAL SEQRES 13 C 198 THR PRO ILE LYS ASP LEU THR ALA HIS PHE ARG GLY ASP SEQRES 14 C 198 ARG CYS LYS THR LEU LEU GLU LYS PRO LYS LEU PHE PHE SEQRES 15 C 198 ILE GLN ALA CYS ARG GLY THR GLU LEU ASP ASP GLY ILE SEQRES 16 C 198 GLN ALA ASP SEQRES 1 D 113 SER GLY PRO ILE ASN ASP THR ASP ALA ASN PRO ARG TYR SEQRES 2 D 113 LYS ILE PRO VAL GLU ALA ASP PHE LEU PHE ALA TYR SER SEQRES 3 D 113 THR VAL PRO GLY TYR ALA SER MET ARG ASN PRO GLY ARG SEQRES 4 D 113 GLY SER TRP PHE VAL GLN ALA LEU CYS SER ILE LEU GLU SEQRES 5 D 113 GLU HIS GLY LYS ASP LEU GLU ILE MET GLN ILE LEU THR SEQRES 6 D 113 ARG VAL ASN ASP ARG VAL ALA ARG HIS PHE GLU SER GLN SEQRES 7 D 113 SER ASP ASP PRO HIS PHE HIS GLU LYS LYS GLN ILE PRO SEQRES 8 D 113 CYS VAL VAL SER MET LEU THR LYS GLU LEU TYR PHE SER SEQRES 9 D 113 GLN LEU GLU HIS HIS HIS HIS HIS HIS SEQRES 1 E 5 ACE VAL GLU ILE ASJ SEQRES 1 F 5 ACE VAL GLU ILE ASJ HET ACE E 0 3 HET ASJ E 4 8 HET ACE F 0 3 HET ASJ F 4 8 HETNAM ACE ACETYL GROUP HETNAM ASJ (3S)-3-AMINO-4-HYDROXYBUTANOIC ACID FORMUL 5 ACE 2(C2 H4 O) FORMUL 5 ASJ 2(C4 H9 N O3) FORMUL 7 HOH *4(H2 O) HELIX 1 AA1 ASP A 79 GLY A 83 5 5 HELIX 2 AA2 GLY A 89 GLY A 105 1 17 HELIX 3 AA3 SER A 115 GLU A 129 1 15 HELIX 4 AA4 ILE A 159 HIS A 165 1 7 HELIX 5 AA5 PHE A 166 LEU A 175 5 10 HELIX 6 AA6 TRP B 240 GLY B 253 1 14 HELIX 7 AA7 GLU B 257 PHE B 273 1 17 HELIX 8 AA8 ASP C 379 GLY C 383 5 5 HELIX 9 AA9 GLY C 389 GLY C 405 1 17 HELIX 10 AB1 SER C 415 GLU C 429 1 15 HELIX 11 AB2 ILE C 459 ALA C 464 1 6 HELIX 12 AB3 HIS C 465 LEU C 475 5 11 HELIX 13 AB4 TRP D 540 GLY D 553 1 14 HELIX 14 AB5 GLU D 557 PHE D 573 1 17 HELIX 15 AB6 ASP D 579 HIS D 583 5 5 SHEET 1 AA112 PHE A 106 ASN A 112 0 SHEET 2 AA112 GLY A 68 ASN A 74 1 N ASN A 74 O TYR A 111 SHEET 3 AA112 PHE A 137 LEU A 142 1 O ILE A 140 N ILE A 71 SHEET 4 AA112 LYS A 179 GLN A 184 1 O GLN A 184 N LEU A 141 SHEET 5 AA112 PHE B 219 TYR B 223 1 O ALA B 222 N PHE A 181 SHEET 6 AA112 CYS B 290 SER B 293 -1 O VAL B 292 N PHE B 221 SHEET 7 AA112 CYS D 590 SER D 593 -1 O SER D 593 N VAL B 291 SHEET 8 AA112 PHE D 519 TYR D 523 -1 N PHE D 521 O VAL D 592 SHEET 9 AA112 LYS C 479 GLN C 484 1 N ILE C 483 O ALA D 522 SHEET 10 AA112 ALA C 434 LEU C 442 1 N LEU C 441 O GLN C 484 SHEET 11 AA112 LYS C 366 ASN C 374 1 N ILE C 371 O ILE C 440 SHEET 12 AA112 PHE C 406 ASN C 412 1 O TYR C 411 N ASN C 374 SHEET 1 AA2 3 GLY A 145 GLU A 146 0 SHEET 2 AA2 3 VAL A 149 GLY A 152 -1 O VAL A 149 N GLU A 146 SHEET 3 AA2 3 GLY A 155 PRO A 158 -1 O GLY A 155 N GLY A 152 SHEET 1 AA3 3 GLY B 238 SER B 239 0 SHEET 2 AA3 3 MET B 232 ASN B 234 -1 N ASN B 234 O GLY B 238 SHEET 3 AA3 3 GLU E 2 ILE E 3 -1 O GLU E 2 N ARG B 233 SHEET 1 AA4 3 GLY C 445 GLU C 446 0 SHEET 2 AA4 3 VAL C 449 GLY C 452 -1 O VAL C 449 N GLU C 446 SHEET 3 AA4 3 GLY C 455 PRO C 458 -1 O GLY C 455 N GLY C 452 SHEET 1 AA5 3 GLY D 538 SER D 539 0 SHEET 2 AA5 3 MET D 532 ASN D 534 -1 N ASN D 534 O GLY D 538 SHEET 3 AA5 3 GLU F 2 ILE F 3 -1 O GLU F 2 N ARG D 533 LINK SG CYS A 186 C ASJ E 4 1555 1555 1.88 LINK SG CYS C 486 C ASJ F 4 1555 1555 1.88 LINK C ACE E 0 N VAL E 1 1555 1555 1.34 LINK C ILE E 3 N ASJ E 4 1555 1555 1.37 LINK C ACE F 0 N VAL F 1 1555 1555 1.34 LINK C ILE F 3 N ASJ F 4 1555 1555 1.36 CRYST1 88.370 88.370 186.491 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011316 0.006533 0.000000 0.00000 SCALE2 0.000000 0.013067 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005362 0.00000